🇺🇸 FDA
Patent

US 6489308

Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions

expired A61KA61K31/145A61K31/198

Quick answer

US patent 6489308 (Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions) held by The Regents of the University of Technology Office of Technology Transfer expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Technology Office of Technology Transfer
Grant date
Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/145, A61K31/198, A61K31/4245, A61K38/57